Order results by:
| Issue | Title | |
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... In multiple sclerosis (MS), the development and introduction of disease-modifying treatments (DMTs ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a) | Abstract similar documents |
| A. N. Boyko | ||
| "... Patient adherence to therapy with multiple sclerosis disease-modifying treatments (MS DMTs ..." | ||
| Vol 15, No 6 (2023) | Russian-Belarusian Expert Council “New opportunities in the treatment of patients with multiple sclerosis” (October 1, 2023). Main conclusions of the first meeting | Abstract similar documents |
| A. N. Boyko, V. V. Vashchilin, O. V. Boyko, A. G. Bunyak, D. S. Kasatkin, D. S. Korobko, S. I. Kulikova, N. V. Mazgo, N. V. Makovskaya, S. A. Sivertseva, I. V. Smagina, T. N. Chernukha | ||
| "... of these drugs in the healthcare system of these countries was determined. Sampeginterferon beta-1a itself ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... of Russian patients to the reproduced disease modifying therapies (DMTs) and features influencing an attitude ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... of first-line MS disease-modifying therapy (DMTs) is a very current issue. Such a boost is needed to reduce ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... in the treatment of the Russian population of patients with RRMS with other MS disease-modifying treatments (DMTs ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... to the development of disease-modifying therapies (DMTs), which are classified into first- and second-line drugs ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prospects for the use of curcumin as an additional treatment for multiple sclerosis | Abstract similar documents |
| V. S. Rogovskii, A. D. Kukushkina, A. N. Boyko | ||
| "... effects (especially when second-line disease-modifying therapies (DMT) are used). In this context ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... 12 (5.1%) of these patients had not previously received disease-modifying therapies (DMTs), i ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... of a greater number of highly effective drugs that alter the course of MS (disease-modyfyung therapies, DMTs ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... and the use of MS disease-modifying treatments (DMTs). The diagnosis of depression was made according ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... высокоэффективного препарата, изменяющего течение РС (ПИТРС), но и условия своевременного и безопасного переключения ..." | ||
| Vol 7, No 2 (2015) | Brain bioelectrical activity changes in patients with poststroke depression and apathy | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, N. A. Georgievskaya | ||
| "... ЭЭГ в бета-диапазоне отмечалась отсроченно. ..." | ||
| Vol 14, No 4 (2022) | The role of oxidative stress in the development of Alzheimer's disease | Abstract similar documents |
| V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya | ||
| "... , воспаление, нарушение регуляции гомеостаза металлов, неправильный фолдинг белков. Нами рассмотрена роль бета ..." | ||
| Vol 11, No 1 (2019) | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Abstract similar documents |
| B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... соответствии с данными литературы являются: бета-амилоид (Aβ) 42, Aβ-40, Aβ-38, sAPPα, sAPPβ, белки t-tau и p ..." | ||
| Vol 11, No 1 (2019) | Primary progressive aphasia | Abstract PDF (Eng) similar documents |
| V. A. Mikhailov, Yu. V. Kotsiubinskaya, N. Yu. Safonova, N. I. Ananieva, I. K. Stulov | ||
| Vol 8, No 3 (2016) | Changes in EEG indices and serotonin concentrations in depression and anxiety disorders | Abstract similar documents |
| I. V. Kichuk, E. A. Petrova, A. A. Mitrofanov, N. V. Solovyeva, V. B. Vilyanov | ||
| "... спектральных характеристик ЭЭГ в бета-диапазоне. При когерентном анализе в бета-диапазоне отмечались ..." | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| Vol 8, No 4 (2016) | USE OF DIMETHYL FUMARATE IN THE TREATMENT OF MULTIPLE SCLEROSIS: CLINICAL AND ECONOMIC ANALYSIS | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, I. A. Shpak, A. M. Sergeev | ||
| "... опережает препараты, изменяющие течение РС (ПИТРС), второй линии натализумаб и финголимод. По клинико ..." | ||
| Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
| V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
| "... назначенных препаратов, изменяющих течение РС (ПИТРС). Пациенты и методы. Проанализированы данные 877 ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... терапии препаратами, изменяющими течение рассеянного склероза (питрс), или ≥1 обострение и соответствующие ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... (ПИТРС). Изучение новых ПИТРС должно проводиться в строгом соответствии с принципами доказательной ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| "... процессы. Использование препаратов, изменяющих течение РС (ПИТРС), привело к значимому снижению частоты ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... патогенетической терапии или одного обострения на фоне принимаемых препаратов, изменяющих течение РС (ПИТРС), что ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... -remitting MS; 14% – secondary progressive MS. 98 (80%) patients received disease modifying therapies (DMTs ..." | ||
| Vol 3, No 4 (2011) | New criteria for diagnosing Alzheimer's disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... диагностику с использованием лабораторных и нейровизуализационных маркеров бета-амилоида, нейронального ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... , изменяющих течение РС (ПИТРС), первой линии на вторую линию терапии. Материал и методы. Обследованы 24 ..." | ||
| Vol 11, No 1 (2019) | Anti-MOG syndrome: two case reports | Abstract PDF (Eng) similar documents |
| A. S. Kotov | ||
| "... присоединением миелита, на фоне лечения интерфероном бета произошел рецидив. Во втором случае у пациентки ..." | ||
| Vol 16, No 2 (2024) | Diagnosis of Alzheimer's disease by using biological markers in posterior cortical atrophy | Abstract similar documents |
| D. A. Grishina, N. A. Khayalieva, V. V. Grinyuk, A. Yu. Tyurina | ||
| "... бета-амилоида в цереброспинальной жидкости, что позволило установить диагноз БА. Обсуждаются ..." | ||
| Vol 8, No 1 (2016) | Migraine and neck pain: Mechanisms of comorbidity | Abstract similar documents |
| A. S. Zenkevich, E. G. Filatova, N. V. Latysheva | ||
| "... головной боли 3-го пересмотра, версия бета, 2013 г. (МКГБ-3 бета). Для оценки функции антиноцицептивных ..." | ||
| Vol 16, No 2 (2024) | Alzheimer's disease: diagnosis and treatment, errors in patient management | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina | ||
| "... биологических маркеров заболевания, отражающих патологическое образование бета-амилоида и тау-протеина в ..." | ||
| Vol 13, No 1 (2021) | Modern approaches to drug treatment for vestibular vertigo | Abstract similar documents |
| M. V. Zamergrad, S. V. Morozova | ||
| "... – Бетасерк® Лонг), глюкокортикоидов и гентамицина – при болезни Меньера; триптанов, бета-адреноблокаторов ..." | ||
| Vol 9, No 4 (2017) | Current approaches to diagnosing and treating major neurocognitive disorder | Abstract similar documents |
| A. A. Kulesh, V. V. Shestakov | ||
| "... , позитронно-эмиссионная томография с индикатором амилоида, а также оценка содержания бета-амилоида и тау ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... и на 14-е сутки исследования. Активность CYP3A оценивали по отношению концентрации 6-бета ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
| Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
| "... 9282641), факторов транскрипции SOX8 (rs2744148) и ZBTB46 (rs6062314), бета-маннозидазы MANBA (rs228614 ..." | ||
| Vol 14, No 6 (2022) | Alzheimer's disease and COVID-19 | Abstract similar documents |
| N. N. Koberskaya, F. A. Roshchin | ||
| "... , опосредованные глиальными клетками, что в свою очередь может привести к накоплению бета-амилоида и последующему ..." | ||
| Vol 12, No 4 (2020) | Diagnosis and treatment of migraine: Russian experts' recommendations | Abstract similar documents |
| E. G. Filatova, V. V. Osipova, G. R. Tabeeva, V. A. Parfenov, E. V. Ekusheva, Yu. E. Azimova, N. V. Latysheva, M. V. Naprienko, K. V. Skorobogatykh, A. V. Sergeev, V. A. Golovacheva, E. R. Lebedeva, A. R. Artyomenko, O. V. Kurushina, M. I. Koreshkina, A. V. Amelin, L. R. Akhmadeeva, A. R. Rachin, E. D. Isagulyan, Al. B. Danilov, A. B. Gekht | ||
| "... показана профилактическая терапия, которая включает антидепрессанты, антиконвульсанты, бета-блокаторы ..." | ||
| Vol 11, No 3 (2019) | he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments | Abstract similar documents |
| I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova, K. M. Naumov, I. A. Lupanov, G. A. Kilivaeva, M. R. Alizade | ||
| "... исследователи считали причиной болезни гиперпродукцию бета-амилоидного белка (Аβ), то в последние годы все чаще ..." | ||
| Vol 10, No 2 (2018) | Diagnostic criteria for transient ischemic attack | Abstract similar documents |
| E. R. Lebedeva, N. M. Gurary, J. Olesen | ||
| "... России (n=152), страдающих мигренью с аурой, у которых диагноз был установлен согласно МГКБ-3 бета ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... маркеров (биомаркеров) БА: снижение уровня бета-амилоида (Ав1-42) и повышение уровня фосфорилированного тау ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... также позитронно-эмиссионная томография (патологическое накопление бета-амилоида и тау-протеина в ..." | ||
| Vol 7, No 1 (2015) | Analysis of the quality of diagnosis and treatment of primary headache in different social groups of the Ural Region | Abstract similar documents |
| E. R. Lebedeva, N. R. Kobzeva, D. V. Gilev, E. Olesen | ||
| "... болей версии 3 бета. Результаты и обсуждение. Выявлены следующие факторы, снижающее качество ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy | Abstract similar documents |
| Yu. A. Belova, T. I. Yaukushina, I. G. Rudakova, S. V. Kotov | ||
| "... : интерферон бета1а (n=2), глатирамера ацетат (n=5). Проведена ретроспективная оценка течения эпилепсии и РС ..." | ||
| 1 - 43 of 43 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
